Average Co-Inventor Count = 5.72
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Depuy Synthes Products, Inc. (17 from 2,684 patents)
2. Ethicon, Gmbh (4 from 3,632 patents)
3. Advanced Technologies and Regenerative Medicine, LLC (3 from 20 patents)
4. Ethicon Endo-surgery, Inc. (1 from 2,207 patents)
5. Cordis Corporation (1 from 954 patents)
6. Rutgers, the State University of New Jersey (1,454 patents)
26 patents:
1. 11191789 - Cartilage and bone repair and regeneration using postpartum-derived cells
2. 11179422 - Method of differentiating umbilical cord tissue into a chondrogenic phenotype
3. 11000554 - Postpartum cells derived from placental tissue, and methods of making and using the same
4. 10500230 - Kidney-derived cells and methods of use in tissue repair and regeneration
5. 10500234 - Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
6. 10413571 - Kidney-derived cells and methods of use in tissue repair and regeneration
7. 10383898 - Postpartum cells derived from placental tissue, and methods of making and using the same
8. 10220059 - Postpartum cells derived from placental tissue, and methods of making and using the same
9. 10195233 - Postpartum cells derived from placental tissue, and methods of making and using the same
10. 9801910 - Decellularized pleural matrix
11. 9717763 - Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
12. 9592258 - Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
13. 9579348 - Encapsulated kidney tissue
14. 9579351 - Postpartum cells derived from placental tissue, and methods of making and using the same
15. 9572840 - Regeneration and repair of neural tissue using postpartum-derived cells